Sonora Investment Management’s Accelerate Diagnostics AXDX Stock Holding History

Sonora Investment Management’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-220	Closed	-$41K	–	1666
2019 Q3	$41K	Hold	220	–	–	﹤0.01%	594
2019 Q2	$50K	Hold	220	–	–	0.01%	546
2019 Q1	$46K	Hold	220	–	–	0.01%	537
2018 Q4	$25K	Hold	220	–	–	﹤0.01%	561
2018 Q3	$50K	Hold	220	–	–	0.01%	413
2018 Q2	$49K	Hold	220	–	–	0.01%	409
2018 Q1	$50.2K	Hold	220	–	–	0.01%	393
2017 Q4	$57.5K	Hold	220	–	–	0.01%	360
2017 Q3	$49.3K	Hold	220	–	–	0.01%	354
2017 Q2	$60K	Hold	220	–	–	0.01%	303
2017 Q1	$53.1K	Hold	220	–	–	0.01%	326
2016 Q4	$45.5K	Hold	220	–	–	0.01%	307
2016 Q3	$59.8K	Hold	220	–	–	0.01%	274
2016 Q2	$31.6K	Hold	220	–	–	0.01%	322
2016 Q1	$28.5K	Buy	220 +40	+22%	+$5.64K	0.01%	375
2015 Q4	$39K	Buy	180 +20	+13%	+$3.65K	0.01%	258
2015 Q3	$30K	Buy	+160	New	+$34.6K	0.01%	264

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Sonora Investment Management's AXDX Position: Q4 2019 in Review

Sonora Investment Management sold out of Accelerate Diagnostics (AXDX) in Q4 2019, closing a stake of 220 shares — an estimated $41K sold.

Sonora Investment Management first reported a position in AXDX in Q3 2015 and held it in 17 quarters. The position peaked at $60K in Q2 2017. 109 funds tracked by Wall St. Rank hold AXDX as of Q4 2019.

Sonora Investment Management reported no remaining Accelerate Diagnostics position as of Q4 2019 after selling out during the quarter.
Sonora Investment Management sold 220 Accelerate Diagnostics shares in Q4 2019, an estimated $41K.
Sonora Investment Management first reported a position in Accelerate Diagnostics in Q3 2015 and held it in 17 quarters.
Sonora Investment Management's Accelerate Diagnostics position peaked at $60K in Q2 2017.
109 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2019.

Based on Sonora Investment Management's 13F filing for Q4 2019, filed 17 Jan 2020.